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Effect of dialysate and substitution fluid buffer on buffer flux in
hemodiafiltration. The effect of differing dialysate and substitution fluid
buffer types and concentrations on acid-base balance have not been
assessed in patients treated with hemodiafiltration for ESRD. To
determine bicarbonate, acetate, lactate and total buffer flux, mass
balance studies were performed in patients treated with hemodiafiltra-
tion using four different combinations of dialysate and substitution
fluids. Driving force for bicarbonate flux was assessed in all treatments.
Bicarbonate flux depended on bicarbonate driving force and ultrafiltra-
tion rate. Bicarbonate flux was negative in all treatment combinations,
even when the driving force was positive. Acetate flux was positive in
all treatment combinations, but the net magnitude was small. Lactate
flux, when lactate containing substitution fluid was used, varied with
dialysate buffer employed during treatment. Overall buffer flux de-
pended on the bicarbonate driving force, ultrafiltration rate, and varied
with the type of substitution and dialysate buffer employed. The types
and concentrations of buffer used in dialysate and substitution fluid
have important effects on the acid-base balance of patients treated with
hemodiafiltration. The long-term implications of different therapeutical
choices in these patients is unknown.
Hemodiafiltration (HDF) is a combined extracorporeal treat-
ment in which convection and diffusion both operate to remove
water, electrolytes, and uremic toxins from the body. Since
large amounts of ultrafiltrate are produced during the treatment,
replacement solutions must be specifically composed, and
infused in proper amounts to maintain desired clinical fluid and
electrolyte balance. Substitution fluid also may serve to correct
metabolic acidosis associated with end-stage renal disease by
replacing buffer base lost through dialysis membranes by con-
vection. Acetate and bicarbonate are generally used as dialy-
sate buffers in hemodialysis, while bicarbonate or lactate are
the typical buffers employed in substitution fluids in hemodi-
afiltration. The type of buffer, and its concentration in both
dialysate and substitution fluid, however, were determined on
the basis of empirical evaluations, rather than by specific
clinical requirements or kinetic studies of acid-base balance.
Our previous studies [11 demonstrated that, despite an accept-
able predialysis blood bicarbonate concentration, patients un-
dergoing hemodiafiltration only achieved a slightly positive
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buffer balance during a single treatment session. This is not
sufficient to completely neutralize a patient's interdialytic daily
acid production.
The present study was designed to evaluate the acid-base
consequences of different buffers employed in the dialysate and
in the substitution fluid in hemodiafiltration.
Methods
Fifteen patients with end-stage renal disease had been treated
with regular dialysis treatments for at least one year before
beginning the present study. No patient had significant residual
renal function as determined by creatinine clearances less than
2 cc/mm. In addition, all studies were performed when patients
were in stable clinical condition.
Kinetic studies of acid-base parameters considered over time
were carried out using four different hemodiafiltration sched-
ules employing different buffers in the dialysate and substitution
fluids. Blood flow was constant in all studies (302 19 mi/mm).
In addition, during study sessions dialysate flow rate (521 43
mi/mm) and treatment time (184 6 mm) were maintained at
constant levels. All studies employed a 1.25 sqm polysulfone
filter (Belico BL627).
Four different combinations of dialysate and substitution
fluids were employed in the study. Fifteen studies were per-
formed using acetate as the dialysate buffer and either lactate or
bicarbonate used as buffer in the substitution fluid. Similarly,
bicarbonate dialysate was employed with either lactate or
bicarbonate used as buffer in the substitution fluid (16 studies).
The number of studies, and the composition of the dialysate and
substitution fluids are given in Table 1. Dialysate and substitu-
tion fluid buffer concentrations were chosen in order to achieve
the widest range of bicarbonate fluxes with which to make
comparisons.
To assess acid-base consequences of the various hemodiafil-
tration schedules, all dialysate was collected under toluene in
order to perform mass balance analysis for bicarbonate and
other buffers.
Determination of bicarbonate concentration in dialysate is
not reliable using blood gas analyzers because the pK of the
solutions is higher than that of blood [2J. Therefore, in order to
estimate bicarbonate concentration, total CO2 concentration
(TCO2) of the dialysate was measured by a Corning 965
(Ciba-Corning Diagnostic, Halstead, Essex, UK) total CO2
analyzer. The pK of the dialysate was calculated for each
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Table 1. Hemodiafiltration schedules
Dialysate Substitution fluid
Acetate dialysateNa 138 mmol/liter a) Na = 140, K = 2, C1 = 108
K' 2 mmol/liter Ca 2.25, Mg = 0.75,Ca + 1.5 mmot/liter Lactate = 40 mmol/liter
Mg 0.75 mmollliter Number of experiments = 7
C1 106.5 mmol/liter b) Na = 140, K = 2, C1 92,
Acetate 40 mmol/liter HC03 = 50 mmol/liter
Number of experiments = 8
Bicarbonate dialysateNa 140 mmol/liter a) Na = 140, K = 2, C1 = 108
K'' 2 mmol/liter Ca = 2,25, Mg = 0.75,Ca + 1.5 inmol/liter Lactate = 40 mmol/liter
Mg 0.7 mmol/liter Number of experiments = 8
C1 1(Y.5—1 10.5 b) Na = 140, K = 2, C1 = 92,
mmol/liter HC03 = 50 mmol/liter
Acetate 5 mmol/liter Number of experiments = 8
HC03 3 1—35 mmol/
liter
particular HDF schedule. The buffer flux equation for each
hemodiafiltration treatment are given in Table 2.
The driving force, Df, as proposed by Sargent and Gotch [4]
was calculated as the difference between the particular buffer
concentration in the inlet dialysate and its blood concentration.
The Df in each individual patient session was calculated as the
mean of seven simultaneous measurements of blood and dialy-
sate buffer concentrations every 30 minutes during the treat-
ment.
Blood pH and pCO2 were determined by a blood gas analyzer
(Radiometer ABL 3, Copenhagen, Denmark). Bicarbonate con-
centration of blood was calculated using the Henderson-Has-
selbalch equation. Acetate concentration was measured using a
spectrophotometric method (Boehringer, Mannheim, Germa-
ny). Lactate concentration was measured by an enzymatic
method using a colorimeter (PAC DuPont, Wilmington, Dela-
ware, USA). All measurements were determined in the inlet
blood and dialysate every 30 minutes during each treatment
session and in the whole collected dialysate.
Analysis of variance (ANOVA) was applied to linear regres-
sion and multiple linear regression.
sample from the ionic strength (calculated from determinations
of sodium, potassium, magnesium, calcium, chloride, phospho-
rus) and the temperature. According to the equilibrium constant
expression, bicarbonate and dissolved CO2 can be determined
by the pK, TCO2, and pH using the following equation:
where K is the antilogarithm of pK, and H is the antilogarithm
of pH. This method of calculating bicarbonate concentration
was used since methods that depend on pCO2 determination are
not reliable, when high pCO2 values (such as in bicarbonate
bath) are present in the solution [31. The volume of dialysate
entering the inlet (V md) was calculated as the difference of the
sum of substitution fluid volume (SV) (9 liters in each treatment)
and the weight lost during the treatment measured in each
patient during each session, subtracted from the volume of
collected dialysate (V outd). The ultrafiltration rate (UF) was
calculated as the volume of substitution fluid infused plus
weight loss divided by the time period of the treatment session.
Buffer flux was calculated for acetate and bicarbonate dialy-
sate hemodiafiltration treatments, using lactate and bicarbonate
substitution fluids. The flux of a particular buffer, Jy, in
mmoLfmin is given by:
(Cy md x V md) — (Cy outd x V outd)
Figure 1 shows the relationship of bicarbonate flux (depicted
along the vertical axis) and the driving force for all hemodiafil-
tration sessions studied. In these studies, bicarbonate flux and
driving force were highly correlated (r =0.93, SE Est = 0.48, F
= 198, P < 0.0001). Bicarbonate flux was always negative, even
when associated with a positive driving force during hemodi-
afiltration treatments using bicarbonate dialysate. In all hemo-
diafiltration treatments using acetate dialysate, the driving force
was negative, and the negative bicarbonate flux was of much
greater magnitude.
Figure 2 depicts the relationship between bicarbonate flux
and ultrafiltration. Ultrafiltration rates (ranging from 52.84 to
103.88 mI/mm) also significantly correlated with bicarbonate
flux during acetate hemodiafiltration (r = 0.87, SE Est = 0.28, F
= 40, P < 0.0001) and bicarbonate hemodiafiltration (r = 0.73,
SE Est = 0.50, F = 15, P = 0.001). In all cases, as ultrafiltration
rate increases, bicarbonate flux decreases.
Figure 3 depicts the relationship between driving force and
bicarbonate flux normalized for ultrafiltration rate magnitude by
multiple linear regression. Each line depicts a multiple linear
regression generated line drawn at a particular ultrafiltration
rate. Multiple linear regression analysis from these points
allows the calculation of the expected bicarbonate flux at a
given ultrafiltration rate or driving force in acetate dialysate
hemodiafiltration (r 0.94, SE Est = 0.18, F 54.6, P < 0.0001)
and in bicarbonate dialy sate hemodiafiltration (r = 0.91, SE Est
= 0.32, F = 30.2, P < 0.0001). Therefore, in either bicarbonate
or acetate hemodiafiltration, bicarbonate flux can be predicted
using the following formulas: Acetate hemodiafiltration
—0.321 — (0.032 x UF) + (0.065 x DO; Bicarbonate hemodi-
afiltration = —0.559 — (0.027 X UF) + (0.105 X DO.
where: Cy is the concentration of buffer y; V is the volume; md
is the inlet dialysate; and outd is the collected dialysate. Jy
represents the mean amount of buffer y transferred per minute
across the hemodiafiltration membrane. If J is positive there is
net buffer y gain by the patient during the procedure. If,
however, J is negative, buffer y balance is negative for that
patient for that session.
The overall buffer flux (J buffers) calculations vary with the
type of substitution fluid and dialysate employed. The term "J
Buffers" includes the fluxes across the dialysis membrane and
the fluxes of substitution fluid of all buffers involved in a
In these studies, there was no difference between mean
acetate flux in the hemodiafiltration treatments using lactate or
FiCO3 mmol/min =
J Lact mmol/min =
time
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Table 2. Buffer flux calculation
Acetate dialysate
HCO3 DI, mmo///iter
—5—1025 —20 —15— I I
Bicarbonate dialysate
5 10 15 20 25
I I I I
bicarbonate containing substitution fluids. Therefore, these two
groups have been combined for analysis. During hemodiafiltra-
tion with acetate dialysate, the mean acetate flux in the 15
experiments was 1.92 0.27 mmol/min. No patients had a
plasma acetate concentration higher than the normal range (0.7
0.20 mmol/liter) at any point during the study. No significant
conelation between acetate flux and ultrafiltration rate was
found.
During hemodiafiltration with bicarbonate dialysate buffer
the mean acetate flux was 0.59 0.11 mmol/min.
Lactate buffer flux
During hemodiafiltration in which lactate was used as the
buffer in substitution fluid, the calculated lactate infusion rate
was (C Lactate S x S V/time) 2 mmol/min. During hemodiafil-
tration with lactate containing substitution fluid, plasma lactate
concentrations were higher during treatments using bicarbonate
dialysate compared to acetate dialysate (Fig. 4); however, the
differences did not reach a level of significance. In both cases,
subject's plasma lactate concentrations peaked two hours after
the beginning of the treatment. As a result of the increase in
patient's mean plasma lactate concentrations, lactate was
cleared during hemodiafiltration sessions using lactate substitu-
tion fluid in treatments in which either acetate or bicarbonate
were used as the dialysate buffer. Net blood losses of lactate
recovered in spent dialysate fluid were significantly higher in
hemodiafiltration sessions in which bicarbonate was used as the
dialysate buffer, compared to sessions in which acetate was
used as the buffer (149.46 33.15 and 65.13 24.54, t = 8.38,
P < 0.01). The net amount of lactate gained by the patient (J
(C HCO3ind x Vind) — (C HCO3outd x Voutd)
time
(C Acetind x Vind) — (C Acetoutd x Voutd)J Acet mmol/min
time
(C lactS x SV) — (C Lactoutd x Voutd)
Overall buffer fluxes (J buffers)
I Schedule: Acetate dialysate & lactate subst. fluid
J buffers (mmol/min) = J Acet + J HCO3 + J Lact
II Schedule: Acetate dialysate & bicarbonate subst. fluid
J buffers (mmol/min) = J Acet + J HCO3' + (C FICO3S x SV)/time
III Schedule: Bicarbonate dialysate & lactate subst. fluid
J buffers (mmol/min) = J Acetb + J HCO3 + J Lact
IV Schedule: Bicarbonate dialysate & Bicarbonate subst. fluid
J buffers (mmol/liter) = J Acetb + J HCO + (C HCO3S x SV)/time
Abbreviations are: C, concentration (mmol/liter); V, volume (liter); i, inlet dialysate; outd, outlet collected dialysate; S, substitution fluid.
a In acetate dialysate HDF, J HCO3 is always negative because C HCO3ind >< Vind is = 0.b In bicarbonate dialysate HDF, J Acet is due to the small amount of acetate (5 mmol/liter) present in the solution to maintain the bicarbonate
stability.
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S
S
—0.5 -
—1.5 —
—
-2-
-2.5
• S (-)
.
I
S • —3.5 -S
S
• S
—4—
• S
—4.5 —
—5
S
• ••
S
Fig. 1. Relationship between bicarbonate driving
force (Df) and bicarbonate flux (JHCO3): N =
31, r = 0.93, SEEst = 0.48, F = 198, P <
0.0001, ultrafiltration range = 52.84 to 103.88
ml/min.
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Fig. 2. Relationship between ultrafiltration (UF) and bicarbonate flux(JHCOJ). Acetate dialysate: N = 15, r = 0.87, SE Est = 0.28, F = 40,
P < 0.0001; driving force range = —24.75 to —13.34 mmol/liter.
Bicarbonate dialysate: N = 16, r = 0.73, SE Est = 0.50, F = 15, P <
0.001, driving force range = 3.46 to 20.52 mmol/Iiter. Symbols are; (•)
bicarbonate dialysate; (A) acetate dialysate.
lactate, see Table 2) was 1.72 0.32 mmol/min during hemo-
diafiltration in which acetate was used in the dialysate, signifi-
cantly higher than the 1.19 0.51 mmollmin in hemodiafiltra-
tion sessions using bicarbonate (t = 3.49, P < 0.01).
Overall buffer balance
Figures 5 and 6 illustrate the relationship between ultrafiltra-
tion rate, and overall buffer flux (J buffers), normalized for the
magnitude of the bicarbonate driving force, Each line depicts a
multiple linear regression generated equation for a particular
driving force gradient. Figure 5 illustrates the overall buffer flux
achieved during hemodiafiltration treatments in which acetate
was used as the dialysate at different driving forces. The two
graphs depict hemodiafiltration sessions in which either lactate
or bicarbonate was used as the buffer in substitution fluid.
Figure 6 illustrates these relationships with fluxes achieved
during hemodiafiltration treatments in which bicarbonate was
used as the buffer in dialysate. Overall buffer flux was defined as
the arithmetic sum of the bicarbonate flux (depicted in Fig. 3),
acetate flux and lactate flux in each of the treatments (Table 2).
These graphs depict the calculated effect of ultrafiltration rate
and level of bicarbonate driving force on overall buffer flux in
each clinical condition. In these figures, overall buffer fluxes are
predicted over a wide range of ultrafiltration rates and driving
force conditions. The area between the two horizontal lines
represents the optimal dialytic buffer gain required to offset the
interdialytic metabolic acid production and the organic ions lost
during dialysis, derived from previous studies of Gotch, Sargent
and Keen [5] and Vreeman and co-workers [61. The hatched
bars indicate typical ultrafiltration rates achieved during clinical
hemodiafiltration. In hemodiafiltration using acetate dialysis
and lactate substitution fluid, at the driving forces depicted,
patients do not reach the positive net overall buffer flux
necessary to achieve optimal interdialytic acid-base balance.
However, when bicarbonate substitution fluid is used, optimal
interdialytic metabolic acid-base balance can be achieved in
patients at lower negative driving forces depicted, but only at
low ultrafiltration rates. In Figure 6, during hemodiafiltration
using bicarbonate dialysate, optimal interdialytic metabolic
acid-base balance may be achieved at clinically utilized ultrafil-
tration rates at driving forces of 15 and 20 mmol/liter. During
hemodiafiltration using bicarbonate substitution fluids, optimal
interdialytic acid-base balance is achieved at a driving force of
only 10 mmol/liter.
Discussion
Over the last several years, newer dialytic techniques have
been designed to improve the efficiency of dialysis, to shorten
treatment time, and to attempt to reduce clinical symptomatol-
ogy during dialysis. These objectives can be achieved by
maximizing both convective and diffusive solute transport
during dialysis. Hemodiafiltration is the prototype of these new
techniques. The types and concentration of buffers used in
dialysate and in substitution fluid for hemodiafiltration were not
determined from the use of clinical studies of acid-base status,
but rather were derived from empirical evaluation of their
clinical adequacy. No study has investigated the clinical impli-
cation of diffusing buffer solution in hemodiafiltration using
acid-base balance techniques. Although estimates of bicarbon-
ate mass transfer can be made using the sum of diffusive and
convective fluxes, the only accurate way to assess bicarbonate
mass balance and net buffer flux is to determine absolute
amounts of bicarbonate and other buffers in spent dialysate by
collecting the volume and measuring individual buffer concen-
trations [I]. In this manner, correct buffer balance can be
calculated if reliable methods for measuring buffer concentra-
tions are used.
Sargent and Gotch [41 suggested that bicarbonate flux in
purely diffusive dialysis is directly proportional to the driving
force, independent of the direction of flux. In their study, using
blood flows of 200 mI/mm, dialysate flows of 336 mI/mm, a
CDAK 1.3 sqm filter, and driving forces ranging from —23 to 18
mmol/liter, bicarbonate flux was negative during acetate dialy-
sis and positive during bicarbonate dialysis. However, these
studies were carried out under conditions of zero net ultrafil-
tration. When the theoretical effect of ultrafiltration on these
parameters was considered, profound changes in bicarbonate
flux were predicted. They suggested that if diffusive and con-
vective fluxes were in the same direction, such as in acetate
dialysis, a higher negative bicarbonate flux would result. In
contrast, if diffusive and convective fluxes were in opposite
directions, as seen in bicarbonate dialysis, a decrease in the
positive bicarbonate flux would be seen. Our data demonstrate
that these concepts are fully applicable to in vivo clinical
hemodiafiltration treatments. We have demonstrated that the
bicarbonate flux is inversely proportional to ultrafiltration rate.
In acetate hemodiafiltration, at high ultrafiltration rates (50 to
100 mI/mm) bicarbonate losses are remarkably increased (ap-
proximately 0.70 mmol/min for every 20 mLlmin of ultrafiltra-
tion).
However, the most surprising result was noted in hemodiafil-
tration treatments using bicarbonate dialysate. Bicarbonate flux
was always negative at studied ultrafiltration rates, regardless
of the magnitude of driving force (Figs. 1, 2). Theoretically,
bicarbonate flux will only become positive during hemodiafil-
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Fig. 3. Bicarbonate flux (JHCO3) expectancy
from ultrafiltration (UF) and bicarbonate
driving force (DJ) (mmollliter). Acetate
dialysate hemodiafiltration = N = 15, r =
0.94, SE Est = 0.18, F = 54.6, P < 0.0001. J
HCO3 = —0.321 — (0.032 x UF) + (0.065 x
DO. Bicarbonate dialysate hemodiafiltration =
N = 16, r = 0.91, SE Est = 0.32, F = 30.2, P
<0.0001. J HCO3 = —0.559 — (0.027 x UF)
+ 0.105 x DO.
tration when bicarbonate dialysate is used and the driving force
is greater than 17.5 mmol/liter (implying a clinical mean plasma
bicarbonate concentration of less than 17.5 mmol/liter, using
our experimental conditions (Fig. 3).
There was no difference in acetate flux in hemodiafiltration
treatments when acetate was employed in the dialysate when
either lactate or bicarbonate was used as the substitution fluid
buffer. Acetate fluxes in acetate dialysate hemodiafiltration
were much lower at the ultrafiltration rates employed in this
study than those noted during clinical acetate hemodialysis
[5—7]. This is probably due to the opposing direction of diffusive
and convective acetate fluxes using acetate dialysate in hemo-
diafiltration. In addition, perhaps some solvent-solute interac-
tions occur which limits diffusive entry of small molecules
against a high convective current. Therefore high ultrafiltration
rates will tend to decrease net positive acetate flux. This view is
indirectly supported by the findings of low plasma acetate levels
in our patients during hemodiafiltration.
In contrast to bicarbonate hemodialysis, it is difficult to
achieve a positive net bicarbonate flux during hemodiafiltration,
no matter what type of dialysate is used. In addition, the
positive acetate flux is lower in hemodiafiltration than in acetate
hemodialysis. Therefore, our studies suggest that the type of
buffer employed in the substitution fluid and the concentration
of the particular buffer used is critical in determining both
interdialytic and intradialytic metabolic acid-base balance in a
treatment with a large convective component.
Lactate flux is usually negative in any extracoporeal renal
replacement therapy regardless of the dialysate buffer em-
ployed. The negative flux is proportional to its plasma level.
When lactate is used as the buffer in substitution fluid in
hemodiafiltration, more lactate is recovered in spent dialysate
with bicarbonate dialysate compared to treatments when ace-
tate is used as the dialysate buffer. This finding suggests that
lactate metabolism was hindered in treatments utilizing lactate
substitution fluids and bicarbonate dialysate. This would result
in slightly (but not significantly) increased levels of circulating
lactate concentration, but in significant effects on net lactate
loss as seen in present studies. This might be a consequence of
a relative increase in systemic pH in treatments using bicarbon-
ate dialysate compared to treatments using acetate dialysate.
This hypothesis is consistent with the fact that lactate metabo-
lism is sensitive to the hydrogen ion concentration of the
medium: when hydrogen concentration decreases, the oxida-
tive decarboxylation of lactate to pyruvate is slower [81.
Moreover, when lactate is employed as the buffer in substi-
tution fluid during hemodiafiltration in which acetate is used in
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Fig. 4. Lactate serum changes during acetate (-U-) and bicarbonate(-A-) IIDF. * Lactate serum normal range.
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Fig. 5. Total buffer fluxes in acetate dialysate
HDF. Symbols are: (-A-) HCO3 Df-15; (--•--)
HCO3 Df-20; (U.) HCO3 Df-25.
the dialysate (Fig, 5A), total buffer fluxes during treatment with
normally used clinical parameters never achieve optimal levels
at any driving force clinically encountered. In contrast, when
bicarbonate instead of lactate is used as the buffer in substitu-
tion fluid (Fig. 5B), overall buffer flux reaches optimal levels
during clinically utilized ultrafiltration rates when the driving
force is high. However, this positive net overall buffer flux is
only sufficient to counterbalance the interdialytic metabolic
acid production and organic ion losses at low ultrafiltration
rates, which may not be clinically useful.
in contrast, in hemodiafiltration when bicarbonate dialysate
is used (Fig. 6) either lactate or bicarbonate containing substi-
tution fluids can lead to optimum positive buffer balance at
clinically utilized ultrafiltration rates for hemodiafiltration (60 to
80 mI/mm).
According to Gennari's hypothesis {9] concerning bicarbon-
ate feedback regulation, predialysis blood bicarbonate levels
are determined by the equilibrium between intradialytic buffer
gain an interdialytic acid production. When intradialytic base
gain is greater than metabolic acid production, bicarbonate
blood levels will increase. At the time of the next treatment, the
increased bicarbonate concentration will decrease the net driv-
ing force, reducing the intradialytic buffer gain. Assuming
constant metabolic acid production in a given patient and
constant buffer content of dialysate, a steady state will
achieved dependent on these parameters.
In hemodiafiltration using a bicarbonate concentration of
mmol/liter in the dialysate and lactate containing substituti
fluid, this equilibrium was reached when patient's mean bic
bonate level during the session was about 20 mmollliter
when the driving force was about 15 mmol/liter). Therefor
since during extracorporeal treatment plasma bicarbonate Ic
els rise, the optimum predialysis blood bicarbonate concentr
tion for this treatment should be about 18 mmollliter. Wh
bicarbonate was employed both in the dialysate and in ti
substitution fluid in hemodiafiltration, at typical clinicall
utilized ultrafiltration rates, an equilibrium point was reached
about a mean bicarbonate concentration of 25 mmol/liter (or
driving force of 10 mmol/liter) (Fig. 6B). Therefore, hemodiaf
tration using bicarbonate substitution fluid and bicarbona
dialysate would seem to be the most physiologically appropria
and therapeutic choice. In this case, optimal acid-base balan
would be achieved with a patient starting hemodiafiltrati
treatment with very mild metabolic acidosis (bicarbonate co
centration approximately 23 mmol/liter), and ending the sessi
with mild metabolic alkalosis (bicarbonate concentration a
proximately 27 mmol/liter).
This predialysis bicarbonate concentration might be clinical
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Fig. 6. Total buffer fluxes in bicarbonate
dialysate HDF. Symbols are: (-A-) HCO3 Df 20
(-S-) HCO3 Df 15; (..•..) HCO1 Df 10.
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optimal for two reasons. First, physiologic systems dependent
on optimal acid-base balance might perform better at more
normal bicarbonate concentrations [101. In addition, recent
work has suggested that bone histomorphometrics in patients
with end-stage renal disease treated with bicarbonate contain-
ing dialysate with higher predialysis bicarbonate concentrations
might be improved [11].
Hemodiafiltration treatments have employed different buffers
in dialysate and in the substitution fluids. Careful studies of
buffer balance can provide a rational approach to hemodiafil-
tration prescriptions in patients. The long-term implication of
such changes are unknown, but achieving better predialysis and
intradialytic acid-base balance would seem to be desirable.
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